Startups
Multiple gears up the Founders and Funders of the world’s generation-defining tech companies with the firepower for scale.
Our role is to enhance their capabilities, culture, communications and commercial success.
The Multiple team have experience of backing, building, growing and selling businesses from early stage startups to global brands in the roles of founder, investor, operator, CMO and CEO.
Multiple’s engagements are focused on brand, culture and growth across the three pillars of an organisation’s ‘operating system’ - the why, the who and the how.
We help to build brand, clarify vision, articulate strategy, define positioning, develop culture, shape organisations, acquire customers and drive growth.
Our role is to enhance their capabilities, culture, communications and commercial success.
The Multiple team have experience of backing, building, growing and selling businesses from early stage startups to global brands in the roles of founder, investor, operator, CMO and CEO.
Multiple’s engagements are focused on brand, culture and growth across the three pillars of an organisation’s ‘operating system’ - the why, the who and the how.
We help to build brand, clarify vision, articulate strategy, define positioning, develop culture, shape organisations, acquire customers and drive growth.
Overview
Location
United Kingdom, England, London
Employees
1-10
Founded date
2015
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 22, 2021 | Synaffix Announces Deal with ProfoundBio Worth up to $246 Million Providing Access to Multiple Novel Linker-Payload Technologies | Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology that enables antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announced the signature of a license and optio... |
| Jul 13, 2021 | Nimbus Therapeutics : Announces $105 Million Private Financing to Advance Pipeline Including Multiple Clinical Programs | Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the closing of a $105 million private financing round. The round was led by BVF Partners L... |
| Jul 13, 2021 | Nimbus Therapeutics Announces $105 Million Private Financing to Advance Pipeline Including Multiple Clinical Programs | |
| Apr 5, 2021 | Meijer Strengthens Diversity & Inclusion Efforts, Invests $1 Million in Multiple Urban League Chapters Across the Midwest | |
| Jun 8, 2020 | PG&E CORPORATION PG&E Corporation : Announces $3.25 Billion Common Stock Investment from Multiple Investors | PG&E Corporation today announced that it has entered into a definitive agreement (the “Investment Agreement”) with a select number of investors, including affiliates of Appaloosa, Third Point LLC, Zimmer Partners and Fidelity Management... |
| Aug 1, 2019 | A Q&A with Multiple, the quiet agency behind many a startup’s success story | When Multiple first started in 2015, the concept of an agency specifically geared to the strategic branding and culture of startups was definitely not new, but the fact that it was starting in Europe definitely was. At the time, I remember ... |
| Nov 24, 2016 | Innovative Multiple Sclerosis treatment receives £1m funding boost | Innovative Multiple Sclerosis treatment receives £1m funding boost 24-11-2016 Cambridgeshire based impact venture LIFNano have been awarded £1m funding by Innovate UK in the Biomedical Catalyst competition, 2016. Add This Share Buttons LIFN... |
| Aug 26, 2010 | Multiple sclerosis researchers receive £100,000 grant from Freemasons | Multiple sclerosis researchers receive £100,000 grant from Freemasons 26-08-2010 Cambridge researchers have received a major grant from The Freemasons’ Grand Charity totalling £100,000. The Provincial Grand Master of Cambridgeshire, Rodney ... |
Reviews 0
FAQ about Multiple London
When was Multiple London founded?
Multiple London was founded in 2015.
What has the press written about Multiple London?
Parsers VC has collected 9 articles mentioning Multiple London, among them “Synaffix Announces Deal with ProfoundBio Worth up to $246 Million Providing Access to Multiple Novel Linker-Payload Technologies” (Jul 22, 2021) and “Nimbus Therapeutics : Announces $105 Million Private Financing to Advance Pipeline Including Multiple Clinical Programs” (Jul 13, 2021).
Is Multiple London still active?
Yes, Multiple London is active; its latest activity on Parsers VC dates from Feb 3, 2022.